Gurnet Point Capital
North America, Massachusetts, United States, Cambridge
Description
Gurnet Point Capital is a private equity firm that invests in de-risked life sciences companies
Investor Profile
Gurnet Point Capital has backed more than 11 startups, with 0 new investments in the last 12 months alone. The firm has led 8 rounds, about 73% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series Unknown, Private Equity rounds (top funding stages).
- Majority of deals are located in United States, Israel, Switzerland.
- Strong thematic focus on Health Care, Biotechnology, Medical.
Stage Focus
- Series A (36%)
- Series Unknown (27%)
- Private Equity (18%)
- Series C (9%)
- Series B (9%)
Country Focus
- United States (82%)
- Israel (9%)
- Switzerland (9%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Pharmaceutical
- Baby
- Consumer Goods
- Wellness
- Clinical Trials
- Therapeutics
- Biopharma
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
